ESR1 and breast carcinoma: Since the ER, PR, Her2/neu and Bcl-2 have prognostic importance in breast cancer and are also targets of drugs that are in clinical use, we also assessed the association between Bag-1 expression and these markers, with the goal of characterizing subsets of patients based on expression of these biomarkers.